Evidence map›Paper›PMID 31713102›Full record

ArticleJournal of neurology2020

Survival in treated idiopathic normal pressure hydrocephalus.

Kerstin Andrén, Carsten Wikkelsø, Nina Sundström, Hanna Israelsson, Simon Agerskov, Katarina Laurell, Per Hellström, Mats Tullberg

Abstract read
In one paragraph

Article in Journal of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Fluid dynamics in aging-related dementias.Neurobiology of disease · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kerstin AndrénHydrocephalus Research Unit, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Blå Stråket 7, 413 45, Gothenburg, Sweden. kerstin.andren@neuro.gu.se.ORCID http://orcid.org/0000-0001-6797-6348
Carsten WikkelsøHydrocephalus Research Unit, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Blå Stråket 7, 413 45, Gothenburg, Sweden.ORCID http://orcid.org/0000-0003-1720-7633
Nina SundströmDepartment of Radiation Sciences, Biomedical Engineering, Umeå University, Umeå, Sweden.ORCID http://orcid.org/0000-0002-3486-5251
Hanna IsraelssonDepartment of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.ORCID http://orcid.org/0000-0002-0125-9589
Simon AgerskovHydrocephalus Research Unit, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Blå Stråket 7, 413 45, Gothenburg, Sweden.ORCID http://orcid.org/0000-0001-6695-7049
Katarina LaurellDepartment of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.ORCID http://orcid.org/0000-0002-7504-8354
Per HellströmHydrocephalus Research Unit, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Blå Stråket 7, 413 45, Gothenburg, Sweden.ORCID http://orcid.org/0000-0001-9803-7271
Mats TullbergHydrocephalus Research Unit, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Blå Stråket 7, 413 45, Gothenburg, Sweden.ORCID http://orcid.org/0000-0003-4997-5266

Funding

Gothenburg Foundation for Neurological Research (ISNF) 1155Stiftelsen Edit Jakobssons Donationsfond 2015-018Swedish State Support for Clinical Research (LUA-ALF) ALFGBG-592841The Gothenburg Medical Society GLS-503421
6 · The paper itself

Abstract

objectiveTo describe survival and causes of death in 979 treated iNPH patients from the Swedish Hydrocephalus Quality Registry (SHQR), and to examine the influence of comorbidities, symptom severity and postoperative outcome.

methodsAll 979 patients operated for iNPH 2004-2011 and registered in the SHQR were included. A matched control group of 4890 persons from the general population was selected by Statistics Sweden. Data from the Swedish Cause of Death Registry was obtained for patients and controls.

resultsAt a median 5.9 (IQR 4.2-8.1) year follow-up, 37% of the iNPH patients and 23% of the controls had died. Mortality was increased in iNPH patients by a hazard ratio of 1.81, 95% CI 1.61-2.04, p < 0.001. More pronounced symptoms in the preoperative ordinal gait scale and the Mini-mental State Examination were the most important independent predictors of mortality along with the prevalence of heart disease. Patients who improved in both the gait scale and in the modified Rankin Scale postoperatively (n = 144) had a similar survival as the general population (p = 0.391). Deaths due to cerebrovascular disease or dementia were more common in iNPH patients, while more controls died because of neoplasms or disorders of the circulatory system.

conclusionsMortality in operated iNPH patients is 1.8 times increased compared to the general population, a lower figure than previously reported. The survival of iNPH patients who improve in gait and functional independence is similar to that of the general population, indicating that shunt surgery for iNPH, besides improving symptoms and signs, can normalize survival.

Indexed as

AgedCerebrospinal Fluid ShuntsComorbidityFemaleHumansHydrocephalus, Normal PressureMaleRisk FactorsSwedenCognitive disordersCohort studiesGait disordersHydrocephalusPrognosis

Identifiers

PMID31713102
PMCPMC7035239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.